☆ 4.5 Letter

GRECCAR 14-a multicentric, randomized, phase II-III study evaluating the tailored management of locally advanced rectal carcinoma after a favourable response to induction chemotherapy: study protocol

COLORECTAL DISEASE (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Neoadjuvant Chemotherapy, Excision, and Observation for Early Rectal Cancer: The Phase II NEO Trial (CCTG CO.28) Primary End Point Results

Hagen F. Kennecke et al.

Summary: The purpose of this phase II trial was to evaluate the outcomes and organ-sparing rate of neoadjuvant chemotherapy followed by transanal excision surgery (TES) in patients with early-stage rectal cancer. The results showed that 57% of patients achieved organ preservation through transanal excision surgery after 3 months of chemotherapy, with minimal change in quality of life and rectal function scores. This study suggests that a 3-month induction chemotherapy can successfully downstage early-stage rectal cancer and allow for well-tolerated organ-preserving surgery.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Add to Collection

Article Medicine, General & Internal

Preoperative Treatment of Locally Advanced Rectal Cancer

Deborah Schrag et al.

Summary: Preoperative FOLFOX chemotherapy is as effective as preoperative chemoradiotherapy for locally advanced rectal cancer eligible for sphincter-sparing surgery.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Add to Collection

Article Surgery

Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial

Wei-Jian Mei et al.

Summary: This study compared the efficacy of neoadjuvant chemotherapy alone and neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer. The results showed that neoadjuvant chemotherapy achieved similar rates of pathological complete response and downstaging compared to neoadjuvant chemoradiotherapy, but with lower incidence of perioperative distant metastasis and preventive ileostomy. CAPOX could be an effective alternative treatment option for patients with locally advanced rectal cancer.

ANNALS OF SURGERY (2023)

Add to Collection

Meeting Abstract Gastroenterology & Hepatology

Preoperative Treatment of Locally Advanced Rectal Cancer

D. Schrag et al.

DISEASES OF THE COLON & RECTUM (2023)

Add to Collection

Review Oncology

The Potential for Overtreatment With Total Neoadjuvant Therapy (TNT): Consider One Local Therapy Instead

Christopher J. Anker et al.

Summary: This narrative review evaluates the differences between Total Neoadjuvant Therapy (TNT) and alternative options in terms of quality of life (QoL) and oncologic outcomes for patients with rectal cancer. Survey data highlight the importance of considering QoL when discussing treatment options. While evidence supports TNT in improving distant metastases-free survival, the overall survival benefit is still unclear. The higher pathologic complete response rate with TNT suggests the potential for overtreatment with surgery, supporting a watch-and-wait approach. For low-risk patients, surgery may not be necessary, and radiation therapy can be omitted. Therefore, this review provides guidance on honoring patient preferences for QoL by avoiding treatments with negligible benefits in oncologic outcomes.

CLINICAL COLORECTAL CANCER (2022)

Add to Collection

Article Gastroenterology & Hepatology

Tailored Strategy for Locally Advanced Rectal Carcinoma (GRECCAR 4): Long-term Results From a Multicenter, Randomized, Open-Label, Phase II Trial

Philippe Rouanet et al.

Summary: This study investigated the long-term outcomes of locally advanced rectal carcinoma patients after tailored radiochemotherapy and induction high-dose chemotherapy. The results suggest that tailoring preoperative radiochemotherapy based on induction treatment response appears promising, but further prospective trials are needed to confirm this strategy.

DISEASES OF THE COLON & RECTUM (2022)

Add to Collection

Article Medicine, General & Internal

Comparison of Survival Among Adults With Rectal Cancer Who Have Undergone Laparoscopic vs Open Surgery A Meta-analysis

Meng Kong et al.

Summary: A meta-analysis comparing laparoscopic and open surgery for rectal cancer showed similar disease-free survival (DFS) rates but significantly better overall survival (OS) rates in the laparoscopic group. These findings support the routine use of laparoscopic surgery for patients with rectal cancer.

JAMA NETWORK OPEN (2022)

Add to Collection

Article

The Multimodal Management of Locally Advanced Rectal Cancer: Making Sense of the New Data

Wouter H. Zwart et al.

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting (2022)

Add to Collection

Article Medicine, General & Internal

PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer

Andrea Cercek et al.

Summary: This study found that mismatch repair-deficient, locally advanced rectal cancer is highly sensitive to PD-1 blockade. Additionally, no adverse events of grade 3 or higher have been reported, and no cases of progression or recurrence have been observed. Longer follow-up is needed to assess the duration of response.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Oncology

Rectal Cancer, Version 2.2022

Al B. Benson et al.

Summary: This article, excerpted from the NCCN Guidelines for Rectal Cancer, focuses on the management of malignant polyps and resectable nonmetastatic rectal cancer. The guidelines have been updated to reflect new data supporting total neoadjuvant therapy, expanded recommendations for radiation therapy, and a nonoperative management technique for patients with a complete response to neoadjuvant therapy.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)

Add to Collection

Article Surgery

Omission of neoadjuvant radiotherapy for clinical T2/N1 and T3N0/1 middle and low rectal cancers with safe circumferential resection margins

Kyung-Ha Lee et al.

Summary: The oncologic benefit of neoadjuvant radiotherapy for moderately advanced rectal cancers with safe circumferential resection margins is uncertain. Omitting neoadjuvant radiotherapy may prevent radiotoxicity and facilitate prompt essential treatment without compromising long-term oncologic outcomes.

ANNALS OF SURGICAL TREATMENT AND RESEARCH (2022)

Add to Collection

Article Surgery

Watch and wait after a clinical complete response in rectal cancer patients younger than 50 years

Renu R. Bahadoer et al.

Summary: This study compared the oncological outcomes of watch and wait strategy in rectal cancer patients aged less than 50 years with those aged 50 years or more. The study found no additional oncological risk in young patients compared with their older counterparts when following a watch-and-wait strategy after a clinical complete response.

BRITISH JOURNAL OF SURGERY (2022)

Add to Collection

Article Surgery

Early response to upfront neoadjuvant chemotherapy (CAPOX) alone in low- and intermediate-risk rectal cancer: a single-arm phase II trial

Xiangbing Deng et al.

Summary: This study aimed to evaluate the effect of neoadjuvant chemotherapy in low- and intermediate-risk stage II/III rectal cancer and explore potential indicators for early prediction of tumor response. The results showed that neoadjuvant chemotherapy achieved good tumor response rates in patients with low- and intermediate-risk rectal cancer, and it is feasible to predict tumor response to neoadjuvant chemotherapy in the early treatment phase.

BRITISH JOURNAL OF SURGERY (2022)

Add to Collection

Article Oncology

Surgical approach for rectal cancer: A network meta-analysis comparing open, laparoscopic, robotic and transanal TME approaches

Odhran K. Ryan et al.

Summary: In the total mesorectal excision (TME) for rectal cancer, there were no significant differences in short- and long-term outcomes among open, laparoscopic, robotic, and transanal TME approaches. Open TME had shorter operating time and more complete TME specimen. Minimally invasive techniques improved postoperative recovery but had longer operating times.

EJSO (2021)

Add to Collection

Editorial Material Oncology

Playing With Dynamite? A Cautious Assessment of TNT

Diana D. Shi et al.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Oncology

Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline

Jennifer Y. Wo et al.

Summary: This guideline provides evidence-based recommendations for neoadjuvant radiation therapy in the treatment of localized rectal cancer, emphasizing the importance of preoperative RT and proposing specific treatment options for different patient populations. For rectal cancer patients, a comprehensive treatment strategy including chemotherapy before and after RT is recommended, with nonoperative management considered in cases of clinical complete response.

PRACTICAL RADIATION ONCOLOGY (2021)

Add to Collection

Article Oncology

Neoadjuvant chemotherapy without radiation as a potential alternative treatment for locally advanced rectal cancer: A metaanalysis

Pei Wu et al.

Summary: The study compared the feasibility and efficacy of neoadjuvant chemotherapy (Neo-CT) versus neoadjuvant chemoradiotherapy (Neo-CRT) for locally advanced rectal cancer patients. It was found that there was no significant difference in overall survival and pathological complete response between the two groups, but the Neo-CT group had lower incidences of anastomotic fistula and temporary colostomy, and higher sphincter preservation rate compared to the Neo-CRT group.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)

Add to Collection

Article Oncology

Impact of radiotherapy on anorectal function in patients with rectal cancer following a watch and wait programme

Marit E. van der Sande et al.

RADIOTHERAPY AND ONCOLOGY (2019)

Add to Collection

Article Oncology

Neoadjuvant Chemotherapy With mFOLFOXIRI Without Routine Use of Radiotherapy for Locally Advanced Rectal Cancer

Jianwei Zhang et al.

CLINICAL COLORECTAL CANCER (2019)

Add to Collection

Article Surgery

Early MRI predictors of disease-free survival in locally advanced rectal cancer from the GRECCAR 4 trial

S. Nougaret et al.

BRITISH JOURNAL OF SURGERY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Session 3: Beyond TME and radiotherapy MRI evaluation of rectal cancer treatment response

U. B. Patel et al.

COLORECTAL DISEASE (2018)

Add to Collection

Review Medicine, General & Internal

Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma

Iosief Abraha et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)

Add to Collection

Article Oncology

Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer

D. Azria et al.

ANNALS OF ONCOLOGY (2017)

Add to Collection

Article Gastroenterology & Hepatology

Tailored Treatment Strategy for Locally Advanced Rectal Carcinoma Based on the Tumor Response to Induction Chemotherapy: Preliminary Results of the French Phase II Multicenter GRECCAR4 Trial

Philippe Rouanet et al.

DISEASES OF THE COLON & RECTUM (2017)

Add to Collection

Article Gastroenterology & Hepatology

Impact of Preoperative Radiotherapy on Anastomotic Leakage and Stenosis After Rectal Cancer Resection: Post Hoc Analysis of a Randomized Controlled Trial

Qiyuan Qin et al.

DISEASES OF THE COLON & RECTUM (2016)

Add to Collection

Article Oncology

Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial

Yanhong Deng et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Clinical impact of tumor volume reduction in rectal cancer following preoperative chemoradiation

Y. B. Han et al.

DIAGNOSTIC AND INTERVENTIONAL IMAGING (2016)

Add to Collection

Article Oncology

Bowel Function 14 Years After Preoperative Short-Course Radiotherapy and Total Mesorectal Excision for Rectal Cancer: Report of a Multicenter Randomized Trial

Tina Yen-Ting Chen et al.

CLINICAL COLORECTAL CANCER (2015)

Add to Collection

Article Oncology

Neoadjuvant Chemotherapy Without Routine Use of Radiation Therapy for Patients With Locally Advanced Rectal Cancer: A Pilot Trial

Deborah Schrag et al.

JOURNAL OF CLINICAL ONCOLOGY (2014)

Add to Collection

Article Oncology

LATE SIDE EFFECTS AND QUALITY OF LIFE AFTER RADIOTHERAPY FOR RECTAL CANCER

Kjersti Bruheim et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)

Add to Collection

Article Medicine, General & Internal

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer

E Kapiteijn et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.